ACTIVE

EXCiPACT

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
236 k €
+10.4% YoY
Gross margin
236,4 k €
+9.7% YoY
Equity
1,1 M €
+26.2% YoY

What does EXCiPACT do?

EXCiPACT is a Non-profit organization incorporated in 2014. Its main activity is: Management consultancy activities. Its registered office is in Bruxelles.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0545.771.884
Incorporation
05/02/2014
Legal form
Non-profit organization
Registered office
Rue Marie de Bourgogne 52
1000 Bruxelles · BruxellesSee on map
Latest accounts
31/12/2024
Activities (NACE)
70200Management consultancy activities· main70220Business and other management consultancy activities94999Activities of other membership organisations n.e.c.94999Activities of other membership organisations n.e.c.
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20242023202220212020
Income statement
Gross margin236,4 k €215,5 k €102,5 k €158,5 k €99,3 k €
EBITDA236,4 k €215,5 k €102,5 k €158,5 k €99,3 k €
Operating result235,2 k €214,7 k €102,5 k €158,5 k €99,3 k €
Net result236 k €213,8 k €98,7 k €156 k €96,1 k €
Balance sheet
Equity1,1 M €900,4 k €686,6 k €587,8 k €431,9 k €
Total assets1,2 M €905,4 k €689,5 k €596,6 k €460,2 k €
Cash1,1 M €60,4 k €38,3 €522,8 k €420,6 k €
Debts2,7 k €1,4 k €2,9 k €8,7 k €28,4 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 4 ended

Active mandates

Jessica Cansler

Director

Active
Kevin McGlue

Director

Active
Morad Amadji

Chairman of the board of directors

Active
Shan Gao

Vice-chairman of the board of directors

Active

Ended mandates

International Pharmaceuticals Excipients Council of China (IPEC China)

Director

Represented by Yu (Bree) Wang

Ended
International Pharmaceuticals Excipients Council of the Americas (IPEC Americas)

Director

Ended
Le Conseil International des Excipients Pharmaceutiques - Europe

Chairman of the board of directors · 0501.816.137

Ended
Le Conseil International des Excipients Pharmaceutiques - Europe

Director · 0501.816.137

Represented by Ian Moore

Ended
At this address

Other companies at this address

CompanyCBE no.
EUROCITY● Active
0443.034.137
Eurocity Holdings● Active
0525.698.230
FEDERATION EUROPEENNE DE L'INDUSTRIE DU SPORT● Active
0470.117.032
La Fédération du Conseil International des Excipients Pharmaceutiques● Active
0823.931.361
Le Conseil International des Excipients Pharmaceutiques - Europe● Active
0501.816.137
Stichting Wereld Dorpen voor Kinderen● Active
0448.127.330
UTOPIA LAB BRUXELLES● Active
0727.824.949
Annual accounts

Full financial information

20242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months
Filing date13/11/202505/06/202427/09/202331/08/202203/09/2021
General meeting05/02/202507/02/202428/02/202324/02/202219/01/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202405/02/202513/11/2025FrenchPDF
Micro model31/12/202307/02/202405/06/2024FrenchPDF
Micro model31/12/202228/02/202327/09/2023FrenchPDF
Micro model31/12/202124/02/202231/08/2022FrenchPDF
Micro model31/12/202019/01/202103/09/2021FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 4 ended

Active mandates

Jessica Cansler

Director

Active
Kevin McGlue

Director

Active
Morad Amadji

Chairman of the board of directors

Active
Shan Gao

Vice-chairman of the board of directors

Active

Ended mandates

International Pharmaceuticals Excipients Council of China (IPEC China)

Director

Represented by Yu (Bree) Wang

Ended
International Pharmaceuticals Excipients Council of the Americas (IPEC Americas)

Director

Ended
Le Conseil International des Excipients Pharmaceutiques - Europe

Chairman of the board of directors · 0501.816.137

Ended
Le Conseil International des Excipients Pharmaceutiques - Europe

Director · 0501.816.137

Represented by Ian Moore

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates13/08/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates04/08/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates02/01/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/07/2022
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates20/03/2020
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates11/06/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Other05/01/2018
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Registered office18/05/2015
    SIEGE SOCIAL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024236 k €↑
  2. 2023
    Annual accounts 2023213,8 k €↑
  3. 2022
    Annual accounts 202298,7 k €↓
  4. 2021
    Annual accounts 2021156 k €↑
  5. 2020
    Annual accounts 202096,1 k €
  6. 05/02/2014
    IncorporationNon-profit organization